Hyaluronidase for treatment of intravenous extravasations: Implementation of an evidence-based guideline in a pediatric population

Journal for Specialists in Pediatric Nursing

Volumn 18, Issue 3, 2013, Pages 253-262

  Hanrahan, Kirsten ^a  

^a UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

Author keywords

Evidence based; Extravasation; Infiltration; Intravenous therapy; Pediatric

Indexed keywords

HYALURONOGLUCOSAMINIDASE;

ARTICLE; CHILD; CONTRAST MEDIUM EXTRAVASATION; EVIDENCE BASED MEDICINE; EVIDENCE-BASED; EXTRAVASATION; HUMAN; INFILTRATION; INTRAVENOUS ADMINISTRATION; PEDIATRIC; PRACTICE GUIDELINE; TREATMENT OUTCOME;

EVIDENCE-BASED; EXTRAVASATION; INFILTRATION; INTRAVENOUS THERAPY; PEDIATRIC;

CHILD; EVIDENCE-BASED MEDICINE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; HYALURONOGLUCOSAMINIDASE; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84880040539     PISSN: 15390136     EISSN: 17446155     Source Type: Journal    
DOI: 10.1111/jspn.12035     Document Type: Article

References (46)

1. Banta, C. (1992). Hyaluronidase. Neonatal Network, 11(6), 103-105.
2. Bausone-Gazda, D., Lefaiver, C. A., & Walters, S. A. (2010). A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. Journal of Infusion Nursing, 33(6), 371-384. doi:10.1097/NAN.0b013e3181f85be2
3. Beauman, S. S., & Swanson, A. (2006). Neonatal infusion therapy: Preventing complications and improving outcomes. Newborn and Infant Nursing Reviews, 6(4), 193-201. doi:10.1053/j.nainr.2006.09.001
4. Bertelli, G., Cafferata, M. A., Ardizzoni, A., Gozza, A., Rosso, R., & Dini, D. (1997). Skin ulceration potential of paclitaxel in a mouse skin model in vivo. Cancer, 79(11), 2266-2269.
5. Bertelli, G., Dini, D., Forno, G. B., Gozza, A., Silvestro, S., Venturini, Pronzato, P. (1994). Hyaluronidase as an antidote to extravasation of Vinca alkaloids: Clinical results. Journal of Cancer Research and Clinical Oncology, 120(8), 505-506.
6. Brown, A. S., Hoelzer, D. J., & Piercy, S. A. (1979). Skin necrosis from extravasation of intravenous fluids in children. Plastic and Reconstructive Surgery, 64(2), 145-150.
7. Camp-Sorrell, D. (1998). Developing extravasation protocols and monitoring outcomes. Journal of Intravenous Nursing, 21(4), 232-239.
8. Cicchetti, S., Jemec, B., & Gault, D. T. (2000). Two case reports of vinorelbine extravasation: Management and review of the literature. Tumori, 86(4), 289-292.
9. Clifton-Koeppel, R. (2006). Wound care after peripheral intravenous extravasation: What is the evidence? Newborn and Infant Nursing Reviews, 6(4), 202-211. doi:10.1053/j.nainr.2006.10.001
10. Cochran, S. T., Bomyea, K., & Kahn, M. (2002). Treatment of iodinated contrast material extravasation with hyaluronidase. Academic Radiology, 9(Suppl. 2), S544-S546.
11. COG Pharmacy Committee, & COG Nursing Clinical Practice Committee: Acute/Palliative Care Section. (2007). Extravasation guidelines. Monrovia, CA: Children's Oncology Group.
12. Davies, J., Gault, D., & Buchdahl, R. (1994). Preventing the scars of neonatal intensive care. Archives of Diseases in Children, 70(1), F50-F51.
13. European Oncology Nursing Society. (2007). Introducing the extravasation guidelines: EONS toolkit, post symposium report. Brussels, Belgium: European Oncology Nursing Society. Retrieved from http://www.esop.li/downloads/guidelines_final.pdf
14. Federle, M. P., Chang, P. J., Confer, S., & Ozgun, B. (1998). Frequency and effects of extravasation of ionic and nonionic CT contrast media during rapid bolus injection. Radiology, 206(3), 637-640.
15. Flemmer, L., & Chan, J. S. (1993). A pediatric protocol for management of extravasation injuries. Pediatric Nursing, 19(4), 355-358, 424.
16. Franck, L. S., Hummel, D., Connell, K., Quinn, D., & Montgomery, J. (2001). The safety and efficacy of peripheral intravenous catheters in ill neonates. Neonatal Network, 20(5), 33-38.
17. Garland, J. S., Dunne, W. M., Jr, Havens, P., Hintermeyer, M., Bozzette, M. A., Wincek, J., Seavers, M. (1992). Peripheral intravenous catheter complications in critically ill children: A prospective study. Pediatrics, 89(6 Pt 2), 1145-1150.
18. Hadaway, L. (2007). Infiltration and extravasation. American Journal of Nursing, 107(8), 64-72. doi:10.1097/01.NAJ.0000282299.03441.c7
19. Hanrahan, K. (2012). Evidence-based practice guideline: Hyaluronidase for treatment of intravenous extravasations. Iowa City, IA: University of Iowa College of Nursing.
20. Infusion Nurses Society. (2011). Infusion nursing standards of practice. Norwood, MA: Wolters Kluwer/Lippincott Williams & Wilkins.
21. Institute of Medicine. (2001). Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academies Press.
22. Khan, M. S., & Holmes, J. D. (2002). Reducing the morbidity from extravasation injuries. Annals of Plastic Surgery, 48(6), 628-632; discussion 632.
23. Kumar, M. M., & Sprung, J. (2003). The use of hyaluronidase to treat mannitol extravasation. Anesthesia and Analgesia, 97(4), 1199-1200.
24. Laurie, S. W., Wilson, K. L., Kernahan, D. A., Bauer, B. S., & Vistnes, L. M. (1984). Intravenous extravasation injuries: The effectiveness of hyaluronidase in their treatment. Annals of Plastic Surgery, 13(3), 191-194.
25. MacCara, M. E. (1983). Extravasation: A hazard of intravenous therapy. Drug Intelligence and Clinical Pharmacy, 17(10), 713-717.
26. Martin, P. H., Carver, N., & Petros, A. J. (1994). Use of liposuction and saline washout for the treatment of extensive subcutaneous extravasation of corrosive drugs. British Journal of Anaethesia, 72(6), 702-704.
27. Montgomery, L. A., Hanrahan, K., Kottman, K., Otto, A., Barrett, T., & Hermiston, B. (1999). Guideline for IV infiltrations in pediatric patients. Pediatric Nursing, 25(2), 167-169, 173-180.
28. Napoli, P., Corradino, B., Badalamenti, G., Tripoli, M., Vieni, S., Furfaro, M. F., Moschella, F. (2005). Surgical treatment of extravasation injuries. Journal of Surgical Oncology, 91(4), 264-268. discussion 268-269. doi:10.1002/jso.20248
29. North Trent Cancer Network. (2008). Extravasation guidelines (Vol. 3). Sheffield: Chemotherapy Strategy Group, Extravasation Sub-Group, North Trent Cancer Network.
30. Paquette, V., McGloin, R., Northway, T., Dezorzi, P., Singh, A., & Carr, R. (2011). Describing intravenous extravasation in children (DIVE Study). Canadian Journal of Hospital Pharmacy, 64(5), 340-345.
31. Pettit, J. (2003). Assessment of the infant with a peripheral intravenous device. Advances in Neonatal Care, 3(5), 230-240.
32. Pettit, J., & Hughes, K. (1999). Neonatal intravenous therapy practices. Journal of Vascular Access Devices, 4(1), 7-16. doi:10.2309/108300899775703689
33. Provost, L. P., & Murray, S. K. (2011). The health care data guide: Learning from data for improvement. San Francisco: John Wiley & Sons.
34. Rosenthal, K. (2007). Reducing the risks of infiltration and extravasation. Nursing, 37 (Suppl Med), 4-8. doi:10.1097/01.NURSE.0000298011.91516.98
35. Sauerland, C., Engelking, C., Wickham, R., & Corbi, D. (2006). Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Oncology Nursing Forum, 33(6), 1134-1141. doi:10.1188/06.ONF.1134-1141
36. Sawatzky-Dickson, D., & Bodnaryk, K. (2006). Neonatal intravenous extravasation injuries: Evaluation of a wound care protocol. Neonatal Network, 25(1), 13-19.
37. Schulmeister, L. (2007). Extravasation management. Seminars in Oncology Nursing, 23(3), 184-190. doi:10.1016/j.soncn.2007.05.003
38. Schulmeister, L. (2009). Vesicant chemotherapy extravasation antidotes and treatments. Clinical Journal of Oncology Nursing, 13(4), 395-398. doi:10.1188/09.CJON.395-398
39. Schulmeister, L. (2011). Extravasation management: Clinical update. Seminars in Oncology Nursing, 27(1), 82-90. doi:10.1016/j.soncn.2010.11.010
40. Sokol, D. K., Dahlmann, A., & Dunn, D. W. (1998). Hyaluronidase treatment for intravenous phenytoin extravasation. Journal of Child Neurology, 13(5), 246-247.
41. Thigpen, J. L. (2007). Peripheral intravenous extravasation: Nursing procedure for initial treatment. Neonatal Network, 26(6), 379-384.
42. Titler, M., & Adam, S. (2005). Guidelines for developing guidelines. Iowa City, IA: University of Iowa College of Nursing Gerontological Nursing Interventions Research Center, Research Translation and Dissemination Core.
43. Tripathi, S., Kaushik, V., & Singh, V. (2008). Peripheral IVs: Factors affecting complications and patency-a randomized controlled trial. Journal of Infusion Nursing, 31(3), 182-188. doi:10.1097/01.NAN.0000317704.03415.b9
44. University HealthSystem Consortium. (2011). Harm score crosswalk: NCC MERP to AHRQ Common Formats. Chicago: UHC Patient Safety Net, University HealthSystem Consortium.
45. Wilkins, C. E., & Emmerson, A. J. (2004). Extravasation injuries on regional neonatal units. Archives of Disease in Childhood. Fetal and Neonatal Edition, 89(3), F274-F275.
46. Zenk, K. E., Dungy, C. I., & Greene, G. R. (1981). Nafcillin extravasation injury. Use of hyaluronidase as an antidote. American Journal of Diseases of Children, 135(12), 1113-1114.